CyberLiver is a late clinical stage Prescription Digital Therapeutics platform for managing and treating Advanced Liver Diseases. We are a pioneer in discovering, developing, and delivering clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement, tracking and management tools for clinicians which are cost-effective and scalable.
We lead the fight against advanced liver disease with prescription digital therapies.
Two of our products have completed phase 2 equivalent clinical trials, third in discovery phase.
1. AlcoChange® – for the treatment of Alcohol-Related Liver Disease (ARLD) patients
2. CirrhoCare® – for remote monitoring and treatment of decompensated cirrhosis patients
For more information, visit us at www.cyberliver.com
Company’s Keywords:
hepatology, digital therapeutics, software as medical device, cirrhosis, alcohol related liver disease, nafld, nash, prescription digital therapeutics
<6
<437000
<2012
Your request has been submitted successfully.
Own or work here?